BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 6694339)

  • 1. [Experiences using acylureido-penicillins (azlocillin, mezlocillin) in pediatrics].
    Weingärtner L; Sitka U; Patsch R; Thiemann HH
    Klin Padiatr; 1984; 196(1):28-35. PubMed ID: 6694339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pharmakokinetic and clinical studies with azlocillin in paediatrics (author's transl)].
    Weingärtner L; Sitka U; Patsch R; Richter I; Thiemann HH
    Klin Padiatr; 1980 Sep; 192(5):419-29. PubMed ID: 7192337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative review of two new wide-spectrum penicillins: mezlocillin and piperacillin.
    Russo J; Russo ME
    Clin Pharm; 1982; 1(3):207-16. PubMed ID: 6224627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of therapeutic efficacy of ureidopenicillins in comparison to sisomicin and cephalotin in experimental infections of rabbits.
    Dzierzanowska D; Klosinska E; Roszkowski W; Patzer J; Jeljaszewicz J
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1981 Sep; 250(3):312-21. PubMed ID: 6458186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro and in vivo action of mezlocillin and azlocillin combined with sisomicin.
    Dzierzanowska D; Jeljaszewicz J
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1983 Sep; 255(2-3):346-55. PubMed ID: 6417945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [In vitro susceptibility of gram-negative bacteria isolated from urinary tract infections to acylureidopenicillins].
    Cerikcioğlu N; Ustaçelebi S; Günalp A
    Mikrobiyol Bul; 1986 Jul; 20(3):139-44. PubMed ID: 3561279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Mezlocillin concentrations in human bone tissue].
    Vent J
    Arzneimittelforschung; 1979; 29(12a):1969-71. PubMed ID: 543904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The effect of infusion rate on pharmacokinetic parameters of azlocillin and mezlocillin].
    Haen E; Remien J; Richter E; Frank U; Adam D
    Arzneimittelforschung; 1985; 35(5):864-8. PubMed ID: 4026911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment with azlocillin in complicated urinary tract infections.
    Alfthan O; Renkonen OV; Ohlsson H
    Arzneimittelforschung; 1979; 29(12a):1979-81. PubMed ID: 543906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical experience with azlocillin.
    Sanders WE
    J Antimicrob Chemother; 1983 May; 11 Suppl B():69-75. PubMed ID: 6619034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Azlocillin, mezlocillin, and piperacillin: new broad-spectrum penicillins.
    Eliopoulos GM; Moellering RC
    Ann Intern Med; 1982 Nov; 97(5):755-60. PubMed ID: 6215872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro activity of piperacillin compared with that of ampicillin, ticarcillin, azlocillin, and mezlocillin.
    Machka K; Dickert H; Braveny I
    Arzneimittelforschung; 1980; 30(2):304-7. PubMed ID: 6445735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activity of azlocillin, carbenicillin, mezlocillin and piperacillin against Pseudomonas aeruginosa.
    Høiby N; Bremmelgaard A; Schouenborg P
    Scand J Infect Dis Suppl; 1981; 29():27-30. PubMed ID: 6458882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pseudomonas infections of the lung treated with azlocillin. Microbiology, pharmacokinetics, clinic.
    Daikos GK; Giamarellou H; Hadjipolydorou K; Kanellakopoulou K
    Arzneimittelforschung; 1979; 29(12a):1976-8. PubMed ID: 120747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Azlocillin and mezlocillin: two new semisynthetic acylureido-penicillins (author's transl)].
    Lode H; Niestrath U; Koeppe P; Langmaack H
    Infection; 1977; 5(3):163-9. PubMed ID: 334673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Degradation of Azlocillin and Mezlocillin / I. Behaviour in biological material and buffer (author's transl)].
    Gundert-Remy U; Weber E
    Arzneimittelforschung; 1981; 31(12):2041-4. PubMed ID: 6460506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharmacokinetic studies on the penetration of azlocillin and mezlocillin into bone and tissue fluid (author's transl)].
    Wittmann DH; Schassan HH; Seidel H
    Arzneimittelforschung; 1981; 31(7):1157-62. PubMed ID: 6456009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The acylampicillins: mezlocillin, piperacillin, and azlocillin.
    Drusano GL; Schimpff SC; Hewitt WL
    Rev Infect Dis; 1984; 6(1):13-32. PubMed ID: 6369480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic studies of azlocillin, mezlocillin, cephalothin and sisomicin in rabbits.
    Dzierzanowska D; Patzer J; Jeljaszewicz J
    Infection; 1982; 10 Suppl 3():S217-20. PubMed ID: 6218118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on the antibacterial activity of two new acylureidopenicillins, mezlocillin and azlocillin.
    Soares LA; Trabulsi LR
    Arzneimittelforschung; 1979; 29(12a):1932-4. PubMed ID: 543893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.